Skip to main content

Table 2 Treatment outcomes for amodiaquine plus sulphadoxine-pyrimethamine against P. falciparum malaria in Papua New Guinea

From: The usefulness of twenty-four molecular markers in predicting treatment outcome with combination therapy of amodiaquine plus sulphadoxine-pyrimethamine against falciparum malaria in Papua New Guinea

 

Study sites

 

Karimui area

South Wosera area

 

n = 80

n = 94

Outcome*

Number (%)

ACPR

57 (71.2)

74 (81.3)

ETF

1 (1.3)

5 (5.5)

LCF

6 (7.5)

1 (1.1)

LPF

16 (20.0)

11 (12.1)

Total TF

23 (28.8)

17 (18.7)

  1. * PCR-corrected values up to Day 28; ACPR, Adequate clinical and parasitological response; ETF, Early treatment failure; LCF, Late clinical failure; LPF, Late parasitological failure; TF, Treatment failure
Back to article page

Malaria Journal

ISSN: 1475-2875

Contact us